Altium Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.46M | Buy |
26,740
+2,516
| +10% | +$137K | 0.1% | 121 |
|
|
2022
Q1 | $1.32M | Buy |
24,224
+3,227
| +15% | +$176K | 0.09% | 130 |
|
|
2021
Q4 | $1.16M | Buy |
20,997
+4,014
| +24% | +$221K | 0.07% | 137 |
|
|
2021
Q3 | $811K | Buy |
16,983
+2,836
| +20% | +$135K | 0.06% | 158 |
|
|
2021
Q2 | $704K | Buy |
14,147
+3,253
| +30% | +$162K | 0.05% | 168 |
|
|
2021
Q1 | $486K | Buy |
10,894
+2,099
| +24% | +$93.6K | 0.04% | 226 |
|
|
2020
Q4 | $405K | Sell |
8,795
-877
| -9% | -$40.4K | 0.04% | 238 |
|
|
2020
Q3 | $455K | Buy |
9,672
+656
| +7% | +$30.9K | 0.05% | 189 |
|
|
2020
Q2 | $460K | Sell |
9,016
-3,266
| -27% | -$167K | 0.05% | 178 |
|
|
2020
Q1 | $582K | Buy |
+12,282
| New | +$582K | 0.08% | 123 |
|
|
2018
Q3 | – | Sell |
-5,294
| Closed | -$267K | – | 310 |
|
|
2018
Q2 | $267K | Buy |
+5,294
| New | +$267K | 0.07% | 201 |
|